Acorda Therapeutics, Inc.
ACOR · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$252,854 | -$65,916 | -$103,954 | -$99,594 |
| Dep. & Amort. | $31,666 | $32,809 | $33,953 | $41,298 |
| Deferred Tax | -$43,177 | $30,669 | -$5,186 | $4,667 |
| Stock-Based Comp. | $478 | $1,493 | $2,995 | $8,100 |
| Change in WC | -$10,831 | $1,698 | $24,935 | -$11,954 |
| Other Non-Cash | $260,734 | -$21,677 | $5,909 | -$3,523 |
| Operating Cash Flow | -$13,984 | -$20,924 | -$41,348 | -$61,006 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$264 | -$136 | -$191 | -$4,390 |
| Net Acquisitions | $0 | $0 | $73,969 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $63,750 |
| Other Inv. Act. | $0 | $0 | $73,943 | $63,750 |
| Investing Cash Flow | -$264 | -$136 | $73,778 | $59,360 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$69,655 | -$1,668 |
| Financing Cash Flow | $0 | $0 | -$69,655 | -$1,668 |
| Forex Effect | $188 | $512 | -$447 | $1,018 |
| Net Chg. in Cash | -$14,060 | -$20,548 | -$37,672 | -$2,296 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,420 | $65,223 | $102,895 | $105,191 |
| End Cash | $30,360 | $44,675 | $65,223 | $102,895 |
| Free Cash Flow | -$14,248 | -$21,060 | -$41,539 | -$65,396 |